Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: An assessment from the ARTEMIS DISK Global Antifungal Surveillance Program

Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: An assessment from the ARTEMIS DISK Global Antifungal Surveillance Program

Geographic differences in frequency and azole resistance among Candida glubrata may impact empiric antifungal therapy choice. We examined geographic variation in isolation and azole susceptibility of C. glabrata. We examined 23 305 clinical isolates of C. glabrata during ARTEMIS DISK global surveill...

Full description

Bibliographic Details
Main Authors: Pfaller, Michael A., Diekema, Daniel J., Gibbs, David L., Newell, Vance A., Barton, Richard, Bijie, H., Bille, J., Chang, Shan-Chwen, Martins, M.L., Duseh, A., Dzierzanowska, D., Ellis, D., Finquelievich, J., Gould, I., Gur, D., Hoosen, A., Lee, K., Mallatova, N., Mallie, M., Ng, Kee Peng, Petrikos, G., Santiago, Axel, Trupl, Jan, Abeelev, Ann MarieVanDen, Wadula, Jeannette, Zaidi, Mussaret, Global Antifungal Surveillance Group, -
Format: Article
Published: Elsevier 2010
Subjects:
R Medicine

Similar Items